News from NYU Langone Health
AI-Assisted Technique Tracks Cells Damaged From Injury, Aging And Disease. (LabMedica)
(7/8) Researchers at NYU Langone Health have developed the Nuclear Morphometric Pipeline (NMP), an innovative tool using artificial intelligence and high-resolution imaging to track senescent cells, which are crucial in wound repair and aging-related diseases such as cancer and heart disease; “Our study demonstrates that specific nuclear morphometrics can serve as a reliable tool for identifying and tracking senescent cells, which we believe is key to future research and understanding of tissue regeneration, aging, and progressive disease,” said Michael N. Wosczyna, PhD, assistant professor, Department of Orthopedic Surgery.
Leading Scientific Organizations Propose 10-Year Ban On Human Genetic Editing. (CNN)
(7/5) A new genetic editing breakthrough enables IVF parents to select embryo traits, prompting experts to warn of potential irreversible consequences, with Dr. Bruce Levine from the University of Pennsylvania expressing safety concerns and calling for a 10-year ban on human genetic editing; Nucleus Genomics offers a tool for screening embryos for medical and non-medical traits, raising ethical concerns about modern eugenics and societal values, as discussed by Art Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics, who questions the ethical implications of restricting children’s freedom and the impact on genetic diversity.
Should Dementia And Other Patients Be Able To Choose Death? (Orange County (CA) Register)
(7/8) Art Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics, discussed medical aid in dying (MAID) laws, expressing support for New York’s traditional-guardrails MAID bill and concern over Canada’s broader approach, stating that “the answer to the slippery slope is to put in stairs.”
What Long Covid Can Teach Us ѵ Future Pandemics. (Washington Post)
The (7/9) “The Trump administration’s budget proposal will cut HHS funding from $127 billion to $93.7 billion, including a 40 percent cut to the National Institutes of Health, which had been an important source of support for long covid research,” with the “multibillion-dollar RECOVER Covid Initiative launched by the NIH” allowing “researchers to set up clinics and study long covid at a ‘much bigger scale than they ever have been before,’” said Leora Horwitz, MD, professor, Departments of Population Health, and Medicine, Division of Hospital Medicine added, “I think they’ve put us in a good position now to recognize similar sorts of conditions of future as-yet-unknown pandemics.”
A ‘Sandwich Generation’ Mom Learned She Had Breast Cancer, Then Lost Her Father. The Hardest Part Was Staying Positive In Front Of Her Kids. (Insider)
(7/9) Mary L. Gemignani, MD, MPH, professor, Department of Surgery, chief, Division of Breast Surgery, and the physician of Katie Asturizaga, who was diagnosed with breast cancer, “told Business Insider that she’s seen an uptick in breast cancer cases among women in their 40s, and even in some patients as young as their 20s,” and “highlighted that patients like Asturizaga often deal with the ‘psychosocial aspects of juggling time-consuming treatments’ with caring for their kids or aging parents.”
Dr Mehnert On The Efficacy Of Sarilumab Plus Ipilimumab, Nivolumab, And Relatlimab In Unresectable Melanoma. (OncLive)
(7/8) Janice Mehnert, MD, professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, presented findings from a phase 2 study at the 2025 ASCO Annual Meeting, revealing a 63.6% overall response rate (ORR) for sarilumab combined with ipilimumab, nivolumab, and relatlimab in patients with unresectable stage III or IV melanoma, which she said was “one of the highest response rates” observed in immune checkpoint inhibition studies; the study reported no unexpected toxicities, with grade 3/4 immune-related adverse effects (irAEs) in 12.1% of patients, significantly lower than in previous studies.
What Your Nightmares May Be Trying To Tell You ѵ Your Health. (Prevention Magazine)
(7/8) A study presented at the European Academy of Neurology Congress 2025 found adults with weekly nightmares were over three times more likely to die prematurely than those who rarely or never had them, exceeding the risk associated with factors like smoking, obesity, poor diet, and inactivity, with Thea Gallagher, PsyD, clinical associate professor, Department of Psychiatry, noting that nightmares “can stem from stress and anxiety, along with depression,” and can also be linked to PTSD or “post-traumatic stress symptoms.”
Study Shows Worsening Health Of US Children Due To Obesity And Depression. (WNYW-TV New York)
(7/8) Rabia A. De Latour, MD, assistant professor, Department of Medicine, Division of Gastroenterology and Hepatology, discussed a study published in JAMA revealing that U.S. children are increasingly suffering from chronic illnesses, such as depression, anxiety, sleep apnea, and obesity, with a 15 to 20 percent rise compared to 2007, attributing this trend to factors like ultra-processed foods, sedentary lifestyles, and technology addiction; she advised moderation in diet, noting, “Hot dogs tend to be ultra processed or heavily processed foods with a lot of additives, and it’s lower quality meat in general,” suggesting burgers as a better choice when prepared with quality meat.
These Beloved French Beauty Staples Are On Rare Sale For Amazon Prime Day – Deals Start At Just $14. (Cosmopolitan)
(7/8) French pharmacy beauty products are on sale during Amazon Prime Day, providing an opportunity to purchase these coveted items at discounted prices; Shari B. Marchbein, MD, clinical assistant professor, the Ronald O. Perelman Department of Dermatology, said, “Because of the FDA’s slow approval process, we are way behind Europe on sunscreen innovations and advanced technology, and the formulas there are completely different.”
News from NYU Langone Hospital—Brooklyn
NYU’s New Kidney Transplant Program Raises Questions For Struggling SUNY Downstate. (Crain's New York Business)
(7/9) NYU Langone Hospital – Brooklyn is launching a new kidney transplant program, becoming the second such program in the borough, which has raised concerns about its potential impact on SUNY Downstate’s existing transplant service; however, Bret Rudy, MD, executive vice president and chief of hospital operation at NYU Langone Hospital—Brooklyn, said the program is expected to serve Brooklyn residents who currently travel to NYU’s Manhattan hospital for transplants, with plans to perform 40 transplants in its first year and up to 100 by its third year.
